Chemical- and radiation-induced haemorrhagic cystitis: Current treatments and challenges

BJU International

Volumn 112, Issue 7, 2013, Pages 885-897

  Payne, Heather ^a   Adamson, Andrew ^b   Bahl, Amit ^c   Borwell, Jonathan ^d   Dodds, David ^e   Heath, Catherine ^f   Huddart, Robert ^g   McMenemin, Rhona ^h   Patel, Prashant ⁱ   Peters, John L ^j   Thompson, Andrew ^k  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^b BASINGSTOKE AND NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

^c BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

^d FRIMLEY PARK HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^e BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^f SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^g Royal Marsden Hospital   (United Kingdom)

^h Northern Centre for Cancer Treatment   (United Kingdom)

ⁱ UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^j WHIPPS CROSS UNIVERSITY HOSPITAL   (United Kingdom)

^k Wrightington Wigan and Leigh NHS Trust   (United Kingdom)

more..

Author keywords

chemical cystitis; haemorrhagic cystitis; hyperbaric oxygen; radiation cystitis; sodium hyaluronate

Indexed keywords

ALUMINUM POTASSIUM SULFATE; AMINOCAPROIC ACID; BCG VACCINE; BLOOD CLOTTING FACTOR 13; BOTULINUM TOXIN A; BUSULFAN; CARBOPLATIN; CHONDROITIN SULFATE; CRYSTAL VIOLET; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ESTROGEN; FORMALDEHYDE; HYALURONIC ACID; IDARUBICIN; IFOSFAMIDE; KETAMINE; MESNA; MITOMYCIN; OXYGEN; PACLITAXEL; PENTOSAN POLYSULFATE; PROSTAGLANDIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TETRACHLORODECAOXIDE; TIAPROFENIC ACID;

ANURIA; ARTIFICIAL EMBOLISM; BLADDER CAPACITY; BLADDER IRRIGATION; BLADDER PERFORATION; BLADDER SPASM; BLADDER SPHINCTER; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CHEMORADIOTHERAPY; CLINICAL FEATURE; CRANBERRY JUICE; CYSTECTOMY; CYSTOSCOPY; DIATHERMY; DISEASE PREDISPOSITION; DRUG MEGADOSE; DYSURIA; FEVER; FISTULA; HEMATURIA; HEMORRHAGIC CYSTITIS; HUMAN; HYPERBARIC OXYGEN; INCIDENCE; LOW LEVEL LASER THERAPY; PATIENT COMPLIANCE; PELVIS; PRIORITY JOURNAL; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REHYDRATION; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TACHYCARDIA; URETEROSTOMY; URINARY DIVERSION; URINARY FREQUENCY; URINARY URGENCY; WEGENER GRANULOMATOSIS;

ANTINEOPLASTIC AGENTS; CYSTITIS; HEMORRHAGE; HUMANS; INCIDENCE; NEOPLASMS; RADIOTHERAPY;

EID: 84885972437     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12291     Document Type: Review

References (131)

1. Manikandan R, Kumar S, Dorairajan LN,. Hemorrhagic cystitis: a challenge to the urologist. Indian J Urol 2010; 26: 159-166
2. Hassan Z,. Management of refractory hemorrhagic cystitis following hematopoietic stem cell transplantation in children. Pediatr Transplant 2011; 15: 348-361
3. Bassi PF, Costantini E, Foley S, Palea S,. Glycosaminoglycan therapy for bladder diseases: emerging new treatments. Eur Urol Suppl 2011; 10: 451-459
4. Mukhtar S, Woodhouse C,. The management of cyclophosphamide-induced haematuria. BJU Int 2010; 105: 908-912
5. Decker DB, Karam JA, Wilcox DT,. Pediatric hemorrhagic cystitis. J Pediatr Urol 2009; 5: 254-264
6. Cancer Research UK. World cancer factsheet. Available at: http://publications.cancerresearchuk.org/downloads/product/CS-FS-WORLD-A4.pdf. Accessed September 2012
7. Miodosky M, Abdul-Hai A, Tsirigotis P, et al. Treatment of post-hematopoietic stem cell transplantation hemorrhagic cystitis with intravesicular sodium hyaluronate. Bone Marrow Transplant 2006; 38: 507-511
8. El-Zimaity M, Saliba R, Chan K, et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters. Blood 2004; 103: 4674-4680
9. Droller MJ, Saral R, Santos G,. Prevention of cyclophosphamide-induced hemorrhagic cystitis. Urology 1982; 20: 256-258
10. Garderet L, Bittencourt H, Sebe P, et al. Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipients. Transplantation 2000; 70: 1807-1811
11. Russell SJ, Vowels MR, Vale T,. Haemorrhagic cystitis in paediatric bone marrow transplant patients: an association with infective agents, GVHD and prior cyclophosphamide. Bone Marrow Transplant 1994; 13: 533-539
12. Sandoval C, Swift M,. Treatment of lymphoid malignancies in patients with ataxia-telangiectasia. Med Pediatr Oncol 1998; 31: 491-497
13. Le Guenno G, Mahr A, Pagnoux C, Dhote R, Guillevin L, French Vasculitis Study Group. Incidence and predictors of urotoxic adverse events in cyclophosphamide-treated patients with systemic necrotizing vasculitides. Arthritis Rheum 2011; 63: 1435-1445
14. Klatersky J,. Side effects of ifosfamide. Oncology 2003; 65 (Suppl. 2): 7-10
15. Lima MV, Ferreira FV, Macedo FY, de Castro Brito GA, Ribeiro RA,. Histological changes in bladders of patients submitted to ifosfamide chemotherapy even with mesna prophylaxis. Cancer Chemother Pharmacol 2007; 59: 643-650
16. Korkmaz A, Topal T, Oter S,. Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation. Cell Biol Toxicol 2007; 23: 303-312
17. Emadi A, Jones RJ, Brodsky RA,. Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol 2009; 6: 638-647
18. Xu LP, Zhang HY, Huang XJ, et al. Hemorrhagic cystitis following hematopoietic stem cell transplantation: incidence, risk factors and association with CMV reactivation and graft-versus-host disease. Chin Med J (Engl) 2007; 120: 1666-1671
19. Tsuboi K, Kishi K, Ohmachi K, et al. Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation. Bone Marrow Transplant 2003; 32: 903-907
20. Tang W, Wang L, Zhao WL, Chen YB, Shen ZX, Hu J,. Intravenous busulfan-cyclophosphamide as a preparative regimen before allogeneic hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia. Biol Blood Marrow Transplant 2011; 17: 1555-1561
21. Carpenter PA, Marshall GM, Giri N, Vowels MR, Russell SJ,. Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia conditioned with busulfan, cyclophosphamide and melphalan. Bone Marrow Transplant 1996; 18: 489-494
22. NCI. Common terminology criteria for adverse events, v3.0 (CTCAE), 2003. Available at: http://ctep.cancer.gov/protocolDevelopment/electronic- applications/docs/ctcaev3.pdf. Accessed June 2013
23. Hassan Z, Remberger M, Svenberg P, et al. Hemorrhagic cystitis: a retrospective single-center survey. Clin Transplant 2007; 21: 659-667
24. Shi-Xia X, Xian-Hua T, Hai-Qin X, Bo F, Xiang-Feng T,. Total body irradiation plus cyclophosphamide versus busulphan with cyclophosphamide as conditioning regimen for patients with leukemia undergoing allogeneic stem cell transplantation: a meta-analysis. Leuk Lymphoma 2010; 51: 50-60
25. Ringdén O, Labopin M, Tura S, et al. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 1996; 93: 637-645
26. Ringdén O, Ruutu T, Remberger M, et al. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group. Blood 1994; 83: 2723-2730
27. Sencer SF, Haake RJ, Weisdorf DJ,. Hemorrhagic cystitis after bone marrow transplantation. Risk factors and complications. Transplantation 1993; 56: 875-879
28. Lazzeri M, Montorsi F,. The therapeutic challenge of 'chronic cystitis': search well, work together, and gain results. Eur Urol 2011; 60: 78-80
29. Lamm D, Persad R, Colombel M, Brausi M,. Maintainance Bacillus Calmette-Guérin: the standard of care for the prophylaxis and management of intermediate- and high-risk non-muscle-invasive bladder cancer. Eur Urol Suppl 2010; 9: 715-734
30. Hall MC, Chang SS, Dalbagni G, et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 2007; 178: 2314-2330
31. Soloway MS, Hepps D, Katkoori D, Ayyathurai R, Manoharan M,. Radical cystectomy for BCG failure: has the timing improved in recent years? BJU Int 2011; 108: 182-185
32. Isaka S, Okano T, Abe K, Shimazaki J,. Sequential instillation therapy with mitomycin C and adriamycin for superficial bladder cancer. Cancer Chemother Pharmacol 1992; 30 (Suppl.): S41-44
33. Witjes JA, Caris CT, Mungan NA, Debruyne FM, Witjes WP,. Results of a randomized phase III trial of sequential intravesical therapy with mitomycin C and bacillus Calmette-Guerin versus mitomycin C alone in patients with superficial bladder cancer. J Urol 1998; 160: 1668-1671
34. Crawford ML, Waller PC, Wood SM,. Severe cystitis associated with tiaprofenic acid. Br J Urol 1997; 79: 578-584
35. Buchbinder R, Forbes A, Kobben F, Boyd I, Snow RM, McNeil JJ,. Clinical features of tiaprofenic acid (surgam) associated cystitis and a study of risk factors for its development. J Clin Epidemiol 2000; 53: 1013-1019
36. Kim SJ, Koh DH, Park JS, Ahn HS, Choi JB, Kim YS,. Hemorrhagic cystitis due to intravesical instillation of gentian violet completely recovered with conservative therapy. Yonsei Med J 2003; 44: 163-165
37. Chen CH, Lee MH, Chen YC, Lin MF,. Ketamine-snorting associated cystitis. J Formos Med Assoc 2011; 110: 787-791
38. Folland DS, Kimbrough RD, Cline RE, Swiggart RC, Schaffner W,. Acute hemorrhagic cystitis. Industrial exposure to the pesticide chlordimeform. JAMA 1978; 239: 1052-1055
39. Sandhu SS, Goldstraw M, Woodhouse CR,. The management of haemorrhagic cystitis with sodium pentosan polysulphate. BJU Int 2004; 94: 845-847
40. Denton AS, Clarke N, Maher J,. Non-surgical interventions for late radiation cystitis in patients who have received radical radiotherapy to the pelvis. Cochrane Database Syst Rev 2002; (3) CD001773
41. Vilar DG, Fadrique GG, Martín IJ, et al. Hyperbaric oxygen therapy for the management of hemorrhagic radio-induced cystitis. Arch Esp Urol 2011; 64: 869-874
42. James ND, Hussain SA, Hall E, et al. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med 2012; 366: 1477-1488
43. Smit SG, Heyns CF,. Management of radiation cystitis. Nat Rev Urol 2010; 7: 206-214
44. Hadjibabaie M, Alimoghaddam K, Shamshiri AR, et al. Continuous bladder irrigation prevents hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. Urol Oncol 2008; 26: 43-46
45. Turkeri LN, Lum LG, Uberti JP, et al. Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous bladder irrigation. J Urol 1995; 153: 637-640
46. Rosenzweig MQ, Schaefer PM, Rosenfeld CS,. Prevention of transplant-related hemorrhagic cystitis using bladder irrigation with sorbitol. Bone Marrow Transplant 1994; 14: 491-492
47. Meisenberg B, Lassiter M, Hussein A, Ross M, Vredenburgh JJ, Peters WP,. Prevention of hemorrhagic cystitis after high-dose alkylating agent chemotherapy and autologous bone marrow support. Bone Marrow Transplant 1994; 14: 287-291
48. Atkinson K, Biggs JC, Golovsky D, et al. Bladder irrigation does not prevent haemorrhagic cystitis in bone marrow transplant recipients. Bone Marrow Transplant 1991; 7: 351-354
49. Trotman J, Nivison-Smith I, Dodds A,. Haemorrhagic cystitis: incidence and risk factors in a transplant population using hyperhydration. Bone Marrow Transplant 1999; 23: 797-801
50. Murphy C, Harden E, Stevens D, Lynch J, Montes V, Herzig R,. The addition of mesna to hyperhydration does not decrease the incidence of hemorrhagic cystitis in patients receiving high-dose cyclophosphamide. Oncol Rep 1994; 1: 265-266
51. Shepherd JD, Pringle LE, Barnett MJ, Klingemann HG, Reece DE, Phillips GL,. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation. J Clin Oncol 1991; 9: 2016-2020
52. Vose JM, Reed EC, Pippert GC, et al. Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial. J Clin Oncol 1993; 11: 1306-1310
53. Katz A, Epelman S, Anelli A, et al. A prospective randomized evaluation of three schedules of mesna administration in patients receiving an ifosfamide-containing chemotherapy regimen: sustained efficiency and simplified administration. J Cancer Res Clin Oncol 1995; 121: 128-131
54. Mace JR, Keohan ML, Bernardy H, et al. Crossover randomized comparison of intravenous versus intravenous/oral mesna in soft tissue sarcoma treated with high-dose ifosfamide. Clin Cancer Res 2003; 9: 5829-5834
55. Khojasteh NH, Zakerinia M, Ramzi M, Haghshenas M,. A new regimen of MESNA (2-mercaptoethanesulfonate) effectively prevents cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplant recipients. Transplant Proc 2000; 32: 596
56. Frustaci S, Foladore S, De Pascale A, et al. Feasibility and efficacy of arginine 2-mercaptoethanesulfonate (ARGIMESNA) in the prevention of hemorragic cystitis from ifosfamide (IFO). Ann Oncol 1992; 3 (Suppl. 2): S115-118
57. Letendre L, Hoagland HC, Gertz MA,. Hemorrhagic cystitis complicating bone marrow transplantation. Mayo Clin Proc 1992; 67: 128-130
58. Ippoliti C, Przepiorka D, Mehra R, et al. Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation. Urology 1995; 46: 811-815
59. Hazewinkel MH, Stalpers LJ, Dijkgraaf MG, et al. Prophylactic vesical instillations with 0.2% chondroitin sulfate may reduce symptoms of acute radiation cystitis in patients undergoing radiotherapy for gynecological malignancies. Int Urogynecol J 2011; 226: 725-730
60. Shao Y, Lu GL, Shen ZJ,. Comparison of intravesical hyaluronic acid instillation and hyperbaric oxygen in the treatment of radiation-induced hemorrhagic cystitis. BJU Int 2012; 109: 691-694
61. Sommariva ML, Sandri SD, Ceriani V,. Efficacy of sodium hyaluronate in the management of chemical and radiation cystitis. Minerva Urol Nefrol 2010; 62: 145-150
62. Delgado JM, Samper P, Garrido J,. Hyaluronic acid in the prevention of radiation-induced cystitis (Abstr.). Proc Am Soc Clin Oncol 2003; 22: 752
63. Samper Ots PM, Lõpez Carrizosa C, Rodríguez A, et al. Vesical instillations of hyaluronic acid to reduce the acute vesical toxicity caused by high-dose brachytherapy do not affect the survival: a five-year follow-up study. Clin Transl Oncol 2009; 11: 828-834
64. Levine LA, Jarrard DF,. Treatment of cyclophosphamide-induced hemorrhagic cystitis with intravesical carboprost tromethamine. J Urol 1993; 149: 719-723
65. Lojanapiwat B, Sripralakrit S, Soonthornphan S, Wudhikarn S,. Intravesicle formalin instillation with a modified technique for controlling haemorrhage secondary to radiation cystitis. Asian J Surg 2002; 25: 232-235
66. Dewan AK, Mohan GM, Ravi R,. Intravesical formalin for hemorrhagic cystitis following irradiation of cancer of the cervix. Int J Gynaecol Obstet 1993; 42: 131-135
67. Vicente J, Rios G, Caffaratti J,. Intravesical formalin for the treatment of massive hemorrhagic cystitis: retrospective review of 25 cases. Eur Urol 1990; 18: 204-206
68. Ho CC, Md Zainuddin Z,. Alum irrigation for the treatment of intractable haematuria. Malays J Med Sci 2009; 16: 66-68
69. Nordling J, van Ophoven A,. Intravesical glycosaminoglycan replenishment with chondroitin sulphate in chronic forms of cystitis. A multi-national, multi-centre, prospective observational clinical trial. Arzneimittelforschung 2008; 58: 328-335
70. Kallestrup EB, Jorgensen SS, Nordling J, Hald T,. Treatment of interstitial cystitis with Cystistat: a hyaluronic acid product. Scand J Urol Nephrol 2005; 39: 143-147
71. Morales A, Emerson L, Nickel JC,. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. Urology 1997; 49 (Suppl.): 111-113
72. Diamantopoulos J, Kapsalis Z, Pliotas G, et al. Use of sodium hyaluronate solution in patients suffering from post-radiation cystitis. ESTRO 2004
73. Gonzalez Patino E, Salvador Garrido N, Cascallar Caneda L, et al. Protective effect on the urinary bladder mucosa of intravesical hyaluronic acid in cervix cancer patients treated with pelvic radiotherapy, weekly chemotherapy and high-dose rate brachytherapy. Presented at 2008 World Congress of Brachytherapy
74. Mañas A, Glaría L, Peña C, et al. Prevention of urinary tract infections in palliative radiation for vertebral metastasis and spinal compression: a pilot study in 71 patients. Int J Radiat Oncol Biol Phys 2006; 64: 935-940
75. Demir HA, Savaş Şen Z, Emir S, Tunç B,. Successful treatment of cyclophosphamide-induced haemorrhagic cystitis with intravesical prostaglandin E1 in a child with non-Hodgkin's lymphoma. Scand J Urol Nephrol 2011; 45: 281-284
76. Miura M, Sasagawa I, Kubota Y, Iijima Y, Sawamura T, Nakada T,. Effective hyperbaric oxygenation with prostaglandin E1 for radiation cystitis and colitis after pelvic radiotherapy. Int Urol Nephrol 1996; 28: 643-647
77. Yamamoto M, Hibi H, Ohmura M, Miyake K,. Successful treatment of hemorrhagic cystitis secondary to cyclophosphamide chemotherapy with intravesical instillation of prostaglandin F2 alpha. Hinyokika Kiyo 1994; 40: 833-835
78. Hemal AK, Praveen BV, Sankaranarayanan A, Vaidyanathan S,. Control of persistent vesical bleeding due to radiation cystitis by intravesical application of 15 (S) 15-methyl prostaglandin F2-alpha. Indian J Cancer 1989; 26: 99-101
79. Ostroff EB, Chenault OW Jr,. Alum irrigation for the control of massive bladder hemorrhage. J Urol 1982; 128: 929-930
80. Efros MD, Ahmed T, Coombe N, Choudhury MS,. Urologic complications of high-dose chemotherapy and bone marrow transplantation. Urology 1994; 43: 355-360
81. Arrizabalaga M, Extramiana J, Parra JL, Ramos C, Díaz González R, Leiva O,. Treatment of massive haematuria with aluminium salts. Br J Urol 1987; 60: 223-226
82. Bogris SL, Johal NS, Hussein I, Duffy PG, Mushtaq I,. Is it safe to use aluminum in the treatment of pediatric hemorrhagic cystitis? A case discussion of aluminum intoxication and review of the literature. J Pediatr Hematol Oncol 2009; 31: 285-288
83. Kanwar VS, Jenkins JJ 3rd, Mandrell BN, Furman WL,. Aluminum toxicity following intravesical alum irrigation for hemorrhagic cystitis. Med Pediatr Oncol 1996; 27: 64-67
84. Seear MD, Dimmick JE, Rogers PC,. Acute aluminum toxicity after continuous intravesical alum irrigation for hemorrhagic cystitis. Urology 1990; 36: 353-354
85. Nakada T, Nakada H, Yoshida Y, et al. Hyperbaric oxygen therapy for radiation cystitis in patients with prostate cancer: a long-term follow-up study. Urol Int 2012; 89: 208-214
86. Oliai C, Fisher B, Jani A, et al. Hyperbaric oxygen therapy for radiation-induced cystitis and proctitis. Int J Radiat Oncol Biol Phys 2012; 84: 733-740
87. Davis M, MacDonald H, Sames C, Nand K,. Severe cyclophosphamide-induced haemorrhagic cystitis treated with hyperbaric oxygen. N Z Med J 2011; 124: 48-54
88. Ajith Kumar S, Prasanth P, Tripathi K, Ghosh P,. Hyperbaric oxygen-A new horizon in treating cyclophosphamide-induced hemorrhagic cystitis. Indian J Urol 2011; 27: 272-273
89. Mohamad Al-Ali B, Trummer H, Shamloul R, Zigeuner R, Pummer K,. Is treatment of hemorrhagic radiation cystitis with hyperbaric oxygen effective? Urol Int 2010; 84: 467-470
90. Heath JA, Mishra S, Mitchell S, Waters KD, Tiedemann K,. Estrogen as treatment of hemorrhagic cystitis in children and adolescents undergoing bone marrow transplantation. Bone Marrow Transplant 2006; 37: 523-526
91. Ordemann R, Naumann R, Geissler G, Bornhauser M, Schuler U, Ehninger G,. Encouraging results in the treatment of haemorrhagic cystitis with estrogen-report of 10 cases and review of the literature. Bone Marrow Transplant 2000; 25: 981-985
92. Ashrani AA, Gabriel DA, Gajewski JL, Jacobs DR Jr, Weisdorf DJ, Key NS,. Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy. Bone Marrow Transplant 2006; 38: 825-828
93. Neheman A, Nativ O, Moskovitz B, Melamed Y, Stein A,. Hyperbaric oxygen therapy for radiation-induced haemorrhagic cystitis. BJU Int 2005; 96: 107-109
94. Chong KT, Hampson NB, Corman JM,. Early hyperbaric oxygen therapy improves outcome for radiation-induced hemorrhagic cystitis. Urology 2005; 65: 649-653
95. Bevers RF, Bakker DJ, Kurth KH,. Hyperbaric oxygen treatment for haemorrhagic radiation cystitis. Lancet 1995; 346: 803-805
96. Bui QC, Lieber M, Withers HR, Corson K, van Rijnsoever M, Elsaleh H,. The efficacy of hyperbaric oxygen therapy in the treatment of radiation-induced late side effects. Int J Radiat Oncol Biol Phys 2004; 60: 871-878
97. Corman JM, McClure D, Pritchett R, Kozlowski P, Hampson NB,. Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen. J Urol 2003; 169: 2200-2202
98. Kalayoǧlu-Beşişik S, Abdul-Rahman IS, Erer B, et al. Outcome after hyperbaric oxygen treatment for cyclophosphamide-induced refractory hemorrhagic cystitis. J Urol 2003; 170: 922
99. Jou YC, Lien FC, Cheng MC, Shen CH, Lin CT, Chen PC,. Hyperbaric oxygen therapy for cyclophosphamide-induced intractable refractory hemorrhagic cystitis in a systemic lupus erythematosus patient. J Chin Med Assoc 2008; 71: 218-220
100. Kuroda I, Kuwata Y, Kakehi Y,. Hyperbaric oxygen therapy for Wegener's granulomatosis with cyclophosphamide-induced hemorrhagic cystitis. Int J Urol 2002; 9: 470-472
101. Miller J, Burfield GD, Moretti KL,. Oral conjugated estrogen therapy for treatment of hemorrhagic cystitis. J Urol 1994; 151: 1348-1350
102. Liu YK, Harty JI, Steinbock GS, Holt HA Jr, Goldstein DH, Amin M,. Treatment of radiation or cyclophosphamide induced hemorrhagic cystitis using conjugated estrogen. J Urol 1990; 144: 41-43
103. Duthie G, Whyte L, Chandran H, Lawson S, Velangi M, McCarthy L,. Introduction of sodium pentosan polysulfate and avoidance of urethral catheterisation: improved outcomes in children with haemorrhagic cystitis post stem cell transplant/chemotherapy. J Pediatr Surg 2012; 47: 375-379
104. Toren PJ, Norman RW,. Cyclophosphamide induced hemorrhagic cystitis successfully treated with pentosanpolysulphate. J Urol 2005; 173: 103
105. Hampson SJ, Woodhouse CR,. Sodium pentosanpolysulphate in the management of haemorrhagic cystitis: experience with 14 patients. Eur Urol 1994; 25: 40-42
106. Karimi M, Zakerinia M, Khojasteh HN, Ramzi M, Ahmad E,. Successful treatment of cyclophosphamide induced intractable hemorrhagic cystitis with recombinant FVIIa (NovoSeven) after allogenic bone marrow transplantation. J Thromb Haemost 2004; 2: 1853-1855
107. Geisler JP, Linnemeier GC, Manahan KJ,. Recombinant factor VIIa to treat late radiation-induced hemorrhagic cystitis: a case report. J Reprod Med 2008; 53: 360-362
108. Connolly SS, D'Arcy FT, Corcoran MO,. Recombinant activated factor VII to control life-threatening haemorrhagic radiation cystitis. Ir J Med Sci 2010; 179: 431-433
109. Demesmay K, Tissot E, Bulabois CE, et al. Factor XIII replacement in stem-cell transplant recipients with severe hemorrhagic cystitis: a report of four cases. Transplantation 2002; 74: 1190-1192
110. Pihusch M, Bacigalupo A, Szer J, et al. Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation. J Thromb Haemost 2005; 3: 1935-1944
111. Singh I, Laungani GB,. Intravesical epsilon aminocaproic acid in management of intractable bladder haemorrhage. Urology 1992; 40: 227-229
112. Wang CH, Fang CC, Chen NC, et al. Cranberry-containing products for prevention of urinary tract infections in susceptible populations: a systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 2012; 172: 988-996
113. Bonetta A, Di Pierro F,. Enteric-coated, highly standardized cranberry extract reduces risk of UTIs and urinary symptoms during radiotherapy for prostate carcinoma. Cancer Manag Res 2012; 4: 281-286
114. Cowan CC, Hutchison C, Cole T, et al. A randomized double-blind placebo-controlled trial to determine the effect of cranberry juice on decreasing the incidence of urinary symptoms and urinary tract infections in patients undergoing radiotherapy for cancer of the bladder or cervix. Clin Oncol (R Coll Radiol) 2012; 24: e31-38
115. Campbell G, Pickles T, D'Yachova Y,. A randomised trial of cranberry versus apple juice in the management of urinary symptoms during external beam radiation therapy for prostate cancer. Clin Oncol (R Coll Radiol) 2003; 15: 322-328
116. Chuang YC, Kim DK, Chiang PH, Chancellor MB,. Bladder botulinum toxin A injection can benefit patients with radiation and chemical cystitis. BJU Int 2008; 102: 704-706
117. Vela-Ojeda J, Tripp-Villanueva F, Sanchez-Cortés E, et al. Intravesical rhGM-CSF for the treatment of late onset hemorrhagic cystitis after bone marrow transplant. Bone Marrow Transplant 1999; 24: 1307-1310
118. Gweon P, Shanberg A,. Treatment of cyclophosphamide induced hemorrhagic cystitis with neodymium:YAG laser in pediatric patients. J Urol 1997; 157: 2301-2302
119. Ravi R,. Endoscopic neodymium:YAG laser treatment of radiation-induced hemorrhagic cystitis. Lasers Surg Med 1994; 14: 83-87
120. Veerasarn V, Boonnuch W, Kakanaporn C,. A phase II study to evaluate WF10 in patients with late hemorrhagic radiation cystitis and proctitis. Gynecol Oncol 2006; 100: 179-184
121. Pomer S, Karcher G, Simon W,. Cutaneous ureterostomy as last resort treatment of intractable haemorrhagic cystitis following radiation. Br J Urol 1983; 55: 392-394
122. Pillay PK, Teh M, Chua EJ, Tan EC, Tung KH, Foo KT,. Haemorrhagic chronic radiation cystitis-following treatment of pelvic malignancies. Ann Acad Med Singapore 1984; 13: 634-638
123. Giné E, Rovira M, Real I, et al. Successful treatment of severe hemorrhagic cystitis after hemopoietic cell transplantation by selective embolization of the vesical arteries. Bone Marrow Transplant 2003; 31: 923-925
124. Palandri F, Bonifazi F, Rossi C, et al. Successful treatment of severe hemorrhagic cystitis with selective vesical artery embolization. Bone Marrow Transplant 2005; 35: 529-530
125. Cho CL, Lai MH, So HS, Kwok KK, Chan JC, Velayudhan V,. Superselective embolisation of bilateral superior vesical arteries for management of haemorrhagic cystitis. Hong Kong Med J 2008; 14: 485-488
126. Perez-Mendoza R, Martinez P, Solares M, Badillo M, Gallo M, Jiménez-Rios MA,. Management of post-radiotherapy hemorrhagic cystitis refractory to conventional treatment. BMC Cancer 2007; 7 (Suppl. 1): A44
127. Harkensee C, Vasdev N, Gennery AR, Willetts IE, Taylor C,. Prevention and management of BK-virus associated haemorrhagic cystitis in children following haematopoietic stem cell transplantation-a systematic review and evidence-based guidance for clinical management. Br J Haematol 2008; 142: 717-731
128. Ribeiro RA, Lima-Junior RCP, Leite CA, et al. Chemotherapy-induced hemorrhagic cystitis: pathogenesis, pharmacological approaches and new insights. J Exp Integr Med 2012; 2: 95-112
129. ClinicalTrials.gov Identifier. NCT01659723. Available at: http://clinicaltrials.gov/ct2/show/NCT01659723. Accessed September 2012
130. Madersbacher H, van Ophoven A, van Kerrebroeck PE,. GAG layer replenishment therapy for chronic forms of cystitis with intravesical glycosaminoglycans-a review. Neurourol Urodyn 2012; 32: 9-18
131. Yin Y, Liao B, Gao Q, Song T, Liu GJ, Wu H,. Interventions for preventing hemorrhagic cystitis in patients undergoing hematopoietic stem cell transplantation. Cochrane Database Syst Rev 2011; (8) CD009212